Premature ejaculation

Reading File
Finding Sources
Finding Sources
Searching PubMed

"premature ejaculation"

Searching the Web

premature ejaculation evaluation treatment guideline AUA SMSNA

Reading File
Reading File
Reading Web Page

https://www.auanet.org/guidelines-and-quality/guidelines/dis…

Reading Article

PMID: 41990123

Premature ejaculation (PE) is common and treatable. It usually means ejaculation occurs earlier than desired, with difficulty delaying it and distress for you or your partner. Lifelong PE often occurs within about 1 minute of penetration from the first sexual experiences, while acquired PE starts later after previously normal control. Campbell-Walsh Urology, p. 2074.
What can help
  • Behavioral approaches: stop-start practice, slower stimulation, condoms, pelvic-floor training, and reducing performance anxiety. Sex therapy can be especially useful when anxiety, relationship stress, or avoidance is involved.
  • Topical numbing products: lidocaine/prilocaine sprays or creams can reduce sensation. Use only as directed and wipe off or use a condom to avoid numbing your partner.
  • Prescription treatment: clinicians may use daily SSRIs, on-demand clomipramine or dapoxetine where available, or topical anesthetics as first-line options. The AUA/SMSNA guideline supports these choices.
  • Treat related issues: erectile dysfunction, prostatitis symptoms, thyroid problems, medication/substance effects, depression, or relationship concerns may contribute, particularly if PE began recently.
Avoid self-medicating with antidepressants or tramadol. Tramadol has dependence and interaction risks and is generally reserved for selected people after first-line options fail.
See a GP, urologist, or sexual-health clinician if this is persistent, distressing, newly developed, or accompanied by erection problems, pain, urinary symptoms, low mood, or relationship strain. Recent evidence also suggests pelvic-floor physiotherapy can be a useful low-risk adjunct, though dapoxetine had greater average delay in one 2026 systematic review (PMID 41990123).
This is a shared conversation. Sign in to Orris to start your own chat.